Related by context. Frequent words. (Click for all words.) 68 GVAX 67 GV# [001] 67 axitinib 67 CYC# 67 PARP inhibitor 66 Laquinimod 66 pertuzumab 66 Erlotinib 65 HuMax CD# 65 registrational trial 65 metastatic hormone refractory 65 Bortezomib 65 Pivotal Phase III 65 Irinotecan 65 Lenalidomide 64 Advexin 64 Torisel 64 Alemtuzumab 64 Sorafenib 64 mTOR inhibitor 64 decitabine 64 Avastin bevacizumab 64 temsirolimus 64 fusion inhibitor 63 IMC A# 63 Pirfenidone 63 MAb 63 tanespimycin 63 integrase inhibitor 63 Sym# 63 Pivotal Trial 63 BAY #-# 63 Telcyta 63 luteinizing hormone releasing 63 Carfilzomib 63 BrachySil 63 abiraterone acetate 63 Bevacizumab 63 ZD# [001] 63 eltrombopag 63 Pivotal Phase 63 ASA# 63 deforolimus 63 abiraterone 63 FLT3 63 Amrubicin 63 IMGN# 63 Panitumumab 63 figitumumab 63 Satraplatin 63 EGFr 63 Zactima 62 androgen independent 62 orally bioavailable 62 angiogenesis inhibitor 62 Diamyd ® 62 Amevive 62 castration resistant prostate cancer 62 Phase Ib clinical 62 drug conjugate 62 thymalfasin 62 Everolimus 62 vandetanib 62 Liraglutide 62 gastrointestinal stromal tumors 62 T DM1 62 SCH # 62 cabazitaxel 62 NeuroVax TM 62 Jevtana 62 Telaprevir 62 Drug Candidate 62 Ofatumumab 62 darapladib 62 Chronic Lymphocytic Leukemia 62 SRT# [003] 62 Maraviroc 62 Asentar 62 nilotinib 62 Nexavar ® 62 LY# [002] 61 iclaprim 61 cangrelor 61 OXi# 61 Heplisav 61 Lapatinib 61 anticancer compound 61 Hycamtin 61 HGS ETR1 61 metastatic renal cell carcinoma 61 Phenoptin 61 dasatinib 61 Xyotax 61 Trastuzumab 61 Leukine 61 calcineurin inhibitors 61 tyrosine kinase inhibitor 61 adecatumumab 61 Phase III Clinical Trial 61 tyrosine kinase inhibitors 61 raltegravir